Clinical Trials Insight: 700013084
Phase of Trial: Phase I
Latest Information Update: 13 Mar 2008
At a glance
- Drugs ENMD 1198 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors CASI Pharmaceuticals
- 25 Oct 2007 Interim results were presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer.
- 23 May 2006 New trial record.